Concepedia

Masayuki Kotoku

MK

Statistics

Publications

9

Citations

315

H-Index

9

Active since

2001

Affiliations

Japan Tobacco (Japan)(Current)

Orphagen Pharmaceuticals (United States)

Japan Tobacco (United States)

Kyoto Prefectural University of Medicine

South Valley University

Masayuki Kotoku is an author at Japan Tobacco (Japan) specializing in medicinal chemistry, pharmacology, and drug design.

ORCID

Publications per year

2001–2021

9

Publications

9

SAR Exploration Guided by LE and Fsp <sup>3</sup> : Discovery of a Selective and Orally Efficacious RORγ Inhibitor

Kazuyuki Hirata, Masayuki Kotoku, Noriyoshi Seki et al. · ACS Medicinal Chemistry Letters · 2015 · 59 citations · Full text

, , +16

Discovery of (1<i>S</i>,2<i>R</i>,3<i>R</i>)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors

Makoto Shiozaki, Katsuya Maeda, Tomoya Miura et al. · Journal of Medicinal Chemistry · 2011 · 51 citations · Full text

, , +11

Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach

Muthuraj Prakash, Yukihiro Itoh, Yoshie Fujiwara et al. · Journal of Medicinal Chemistry · 2021 · 40 citations · Full text

, , +13

9‐Fluoro‐18‐hydroxy‐[3.3]metacyclophane: Synthesis and Estimation of a C−F···H−O Hydrogen Bond

Hiroyuki Takemura, Masayuki Kotoku, M. Yasutake et al. · European Journal of Organic Chemistry · 2004 · 37 citations

, , +10

Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold

Masayuki Kotoku, Takaki Maeba, Shingo Fujioka et al. · Journal of Medicinal Chemistry · 2019 · 31 citations · Full text

, , +17

1–5 of 9